GlycA as a new biomarker in rheumatoid arthritis

The research group in Immunology at the University of Oviedo with the participation of Dr. Javier Rodríguez-Carrio has published a study in which one of the variables from our glycoprotein test has been identified as an emerging biomarker for stratification and decision-making in early-stage rheumatoid arthritis. If you want to know more about this publication, click here.

The glycoprotein test is part of our serum metabolomics analysis and its parameters allow us to know the inflammatory state, if you want to see the parameters included in the test, see the Inflammation section of our brochure.